Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Sodium-pump gene-expression, protein abundance and enzyme activity in isolated nephron segments of the aging rat kidney.

Scherzer P, Gal-Moscovici A, Sheikh-Hamad D, Popovtzer MM.

Physiol Rep. 2015 Jun;3(6). pii: e12369. doi: 10.14814/phy2.12369.

2.

A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease.

Zhang Y, Lapidos KA, Gal-Moscovici A, Sprague SM, Ameer GA.

Artif Organs. 2014 Jun;38(6):474-83. doi: 10.1111/aor.12203. Epub 2013 Nov 11.

3.

Psammomys obesus, a particularly important animal model for the study of the human diabetic nephropathy.

Scherzer P, Katalan S, Got G, Pizov G, Londono I, Gal-Moscovici A, Popovtzer MM, Ziv E, Bendayan M.

Anat Cell Biol. 2011 Sep;44(3):176-85. doi: 10.5115/acb.2011.44.3.176. Epub 2011 Sep 29.

4.

Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure.

Shuvy M, Abedat S, Beeri R, Valitsky M, Daher S, Kott-Gutkowski M, Gal-Moscovici A, Sosna J, Rajamannan NM, Lotan C.

Am J Physiol Heart Circ Physiol. 2011 May;300(5):H1829-40. doi: 10.1152/ajpheart.00240.2010. Epub 2011 Feb 18.

5.

Use of vitamin D in chronic kidney disease patients.

Gal-Moscovici A, Sprague SM.

Kidney Int. 2010 Jul;78(2):146-51. doi: 10.1038/ki.2010.113. Epub 2010 May 26. Review.

6.

Histopathology and apoptosis in an animal model of reversible renal injury.

Shuvy M, Nyska A, Beeri R, Abedat S, Gal-Moscovici A, Rajamannan NM, Lotan C.

Exp Toxicol Pathol. 2011 May;63(4):303-6. doi: 10.1016/j.etp.2010.02.002. Epub 2010 Feb 23.

7.

Evidence of a parathyroid hormone-independent chronic effect of estrogen on renal phosphate handling and sodium-dependent phosphate cotransporter type IIa expression.

Guttmann-Rubinstein L, Lichtstein D, Ilani A, Gal-Moscovici A, Scherzer P, Rubinger D.

Horm Metab Res. 2010 Apr;42(4):230-6. doi: 10.1055/s-0029-1246182. Epub 2010 Jan 29.

PMID:
20119884
8.

Role of bone biopsy in stages 3 to 4 chronic kidney disease.

Gal-Moscovici A, Sprague SM.

Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3:S170-4. doi: 10.2215/CJN.01100307. Review.

9.

Role of vitamin D deficiency in chronic kidney disease.

Gal-Moscovici A, Sprague SM.

J Bone Miner Res. 2007 Dec;22 Suppl 2:V91-4. doi: 10.1359/jbmr.07s203. Review.

10.

Osteoporosis and chronic kidney disease.

Gal-Moscovici A, Sprague SM.

Semin Dial. 2007 Sep-Oct;20(5):423-30. Review.

PMID:
17897249
11.

Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?

Gal-Moscovici A, Sprague SM, Hutchison AJ, Shah N, Piraino B, Cunningham J.

Semin Dial. 2007 Jan-Feb;20(1):24-32. Review. No abstract available.

PMID:
17244115
12.
13.

Bone health in chronic kidney disease-mineral and bone disease.

Gal-Moscovici A, Sprague SM.

Adv Chronic Kidney Dis. 2007 Jan;14(1):27-36. Review.

PMID:
17200041
14.

Treatment of osteoporotic ovariectomized rats with 24,25(OH)2D3.

Gal-Moscovici A, Gal M, Popovtzer MM.

Eur J Clin Invest. 2005 Jun;35(6):375-9.

PMID:
15948898
15.
16.

Regulation of NaPi-IIa mRNA and transporter protein in chronic renal failure: role of parathyroid hormone (PTH) and dietary phosphate (Pi).

Elhalel MD, Wald H, Rubinger D, Gal-Moscovici A, Inoue M, Levi M, Popovtzer MM.

Pflugers Arch. 2004 Dec;449(3):265-70.

PMID:
15452708
17.

Stimulation of osteoclastic bone resorption in a model of glycerol-induced acute renal failure: evidence for a parathyroid hormone-independent mechanism.

Gal-Moscovici A, Scherzer P, Rubinger D, Weiss R, Dranitzki-Elhalel M, Popovtzer MM.

Bone. 2002 Oct;31(4):488-91.

PMID:
12398944
18.
19.

Supplemental Content

Loading ...
Support Center